A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: Evidence from 15,857 subjects

Lung Cancer

Volumn 66, Issue 1, 2009, Pages 15-21

  Li, Yan ^a   Qiu, Li Xin ^b   Shen, Xiao Kun ^a   Lv, Xiao Jing ^a   Qian, Xiao Ping ^c   Song, Yong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Genetic polymorphism; Lung cancer; Meta analysis; Molecular epidemiology; Susceptibility; TP53 gene

Indexed keywords

PROTEIN P53;

ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; CODON; CONTROLLED STUDY; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOTE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MOLECULAR EPIDEMIOLOGY; PRIORITY JOURNAL; SMOKING;

ASIAN CONTINENTAL ANCESTRY GROUP; CODON; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROLINE; SMOKING;

EID: 68949217975     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.12.009     Document Type: Article

References (52)

1. Levine A.J. P53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
2. Szymańska K., and Hainaut P. TP53 and mutations in human cancer. Acta Biochim Pol 50 (2003) 231-238
3. Sidransky D., and Hollstein M. Clinical implications of the p53 gene. Annu Rev Med 47 (1996) 285-301
4. Lee J.M., Lee Y.C., Yang S.Y., Shi W.L., Lee C.J., and Luh S.P. Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 89 (2000) 458-464
5. Belyavskaya V.A., Vardosanidze V.K., Smirnova O.Y., Karakin E.I., Sav-kin I.V., Gervas P.A., et al. Genetic status of p53 in stomach cancer: somatic mutations and polymorphism of codon 72. Bull Exp Biol Med 141 (2006) 243-246
6. Agorastos T., Masouridou S., Lambropoulos A.F., Chrisafi S., Miliaras D., Pantazis K., et al. P53 codon 72 polymorphism and correlation with ovarian and endometrial cancer in Greek women. Eur J Cancer Prev 13 (2004) 277-280
7. Zehbe I., Voglino G., Wilander E., Delius H., Marongiu A., Edler L., et al. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res 61 (2001) 608-611
8. Chen W.C., Tsai F.J., Wu J.Y., Wu H.C., Lu H.F., and Li C.W. Distributions of p53 codon 72 polymorphism in bladder cancer-proline form is prominent in invasive tumour. Urol Res 28 (2000) 293-296
9. Weston A., Perrin L.S., Forrester K., Hoover R.N., Trump B.F., and Harris C.C. Allelic frequency of a p53 polymorphism in human lung cancer. Cancer Epidemiol Biomarkers Prev 1 (1992) 481-483
10. Pietsch E.C., Humbey O., and Murphy M.E. Polymorphisms in the p53 pathway. Oncogene 25 (2006) 1602-1611
11. Thomas M., Kalita A., Labrecque S., Pim D., Banks L., and Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19 (1999) 1092-1100
12. Wang Y.C., Chen C.Y., Chen S.K., Chang Y.Y., and Lin P. P53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin Cancer Res 5 (1999) 129-134
13. Pierce L.M., Sivaraman L., Chang W., Lum A., Donlon T., Seifried A., et al. Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population. Cancer Epidemiol Biomarkers Prev 9 (2000) 1199-1204
14. Hiraki A., Matsuo K., Hamajima N., Ito H., Hatooka S., Suyama M., et al. Different risk relations with smoking for non-small-cell lung cancer: comparison of TP53 and TP73 genotypes. Asian Pac J Cancer Prev 4 (2003) 107-112
15. Matakidou A., Eisen T., and Houlston R.S. TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 18 (2003) 377-385
16. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 19 (1955) 251-253
17. Egger M., Smith D.G., Schneider M., and Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
18. Weston A., Ling-Cawley H.M., Caporaso N.E., Bowman E.D., Hoover R.N., Trump B.F., et al. Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. Carcinogenesis 15 (1994) 583-587
19. Wu X., Zhao H., Amos C.I., Shete S., Makan N., Hong W.K., et al. P53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst 94 (2002) 681-690
20. Miller D.P., Liu G., De Vivo L., Lynch T.J., Wain J.C., Su L., et al. Combinations of the variant genotypes of GSTP1, GSTM1 and p53 are associated with an increased lung cancer risk. Cancer Res 62 (2002) 2819-2823
21. Papadakis E.D., Soulitzis N., and Spandidos D.A. Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes. Br J Cancer 87 (2002) 1013-1018
22. Jin X., Wu X., Roth J.A., Amos C.I., King T.M., Branch C., et al. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis 16 (1995) 2205-2208
23. Nadji S.A., Mahmoodi M., Ziaee A.A., Naghshvar F., Torabizadeh J., Yahyapour Y., et al. An increased lung cancer risk associated with codon 72 polymorphism in the TP53 gene and human papillomavirus infection in Mazandaran province, Iran. Lung Cancer 56 (2007) 145-151
24. Murata M., Tagawa M., Kimura M., Kimura H., Watanabe S., and Saisho H. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis 17 (1996) 261-264
25. Fan R., Wu M.T., Miller D., Wain J.C., Kelsey K.T., Wiencke J.K., et al. The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 9 (2000) 1037-1042
26. Biros E., Kalina I., Kohut A., Stubna J., and Salagovic J. Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer. Lung Cancer 31 (2001) 157-162
27. Birgander R., SjaÈlander A., Rannug A., Alexandrie A.K., Ingelman Sundberg M., Seidegard J., et al. P53 polymorphisms and haplotypes in lung cancer. Carcinogenesis 16 (1995) 2233-2236
28. To-Figueras J., Gene M., Gomez-Catalan J., Galan C., Firvida J., Fuentes M., et al. Glutathione-S transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 5 (1996) 337-342
29. Murata M., Tagawa M., Kimura H., Kakisawa K., Shirasawa H., and Fujisawa T. Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small lung cancer patients. Int J Oncol 12 (1998) 577-581
30. Liu G., Miller D.P., Zhou W., Thurston S.W., Fan R., Xu L.L., et al. Differential association of the codon 72 p53 and GSTM1 polymorphisms on the histological subtype of non-small cell lung carcinoma. Cancer Res 61 (2001) 8718-8722
31. Biros E., Kalina I., Biros I., Kohut A., Bogyiova E., Salagovic J., et al. Polymorphism of the p53 gene within the codon 72 in lung cancer patients. Neoplasma 48 (2001) 407-411
32. Irarrázabal C.E., Rojas C., Aracena R., Márquez C., and Gil L. Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53. Toxicol Lett 144 (2003) 69-76
33. Jain N., Singh V., Hedau S., Kumar S., Daga M.K., Dewan R., et al. Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest 128 (2005) 3999-4007
34. Sakiyama T., Kohno T., Mimaki S., Ohta T., Yanagitani N., Sobue T., Kunitoh H., et al. Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int J Cancer 114 (2005) 730-737
35. Zhang X.M., Miao X., Guo Y., Tan W., Zhou Y., Sun T., et al. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer. Hum Mutat 27 (2006) 110-117
36. Szymanowska A., Jassem E., Dziadziuszko R., Borg A., Limon J., Kobierska-Gulida G., et al. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism. Lung Cancer 52 (2006) 9-14
37. Popanda O., Edler L., Waas P., Schattenberg T., Butkiewicz D., Muley T., et al. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms. Lung Cancer 55 (2007) 25-34
38. Giuliani L., Jaxmar T., Casadio C., Gariglio M., Manna A., D'Antonio D., et al. Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer 57 (2007) 273-281
39. Mechanic L.E., Bowman E.D., Welsh J.A., Khan M.A., Hagiwara N., Enewold L., et al. Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African-Americans and somatic mutations in lung tumors. Cancer Epidemiol Biomarkers Prev 16 (2007) 214-222
40. Sreeja L., Syamala V., Raveendran P.B., Santhi S., Madhavan J., and Ankathil R. p53 Arg72Pro polymorphism predicts survival outcome in lung cancer patients in Indian population. Cancer Invest 26 (2008) 41-46
41. Fernández-Rubio A., López-Cima M.F., González-Arriaga P., García-Castro L., Pascual T., Marrón M.G., et al. The TP53 Arg72Pro polymorphism and lung cancer risk in a population of Northern Spain. Lung Cancer 61 (2008) 309-316
42. Honma H.N., De Capitani E.M., Perroud M.W., Barbeiroa A.S., Toro I.F., Costa D.B., et al. Influence of p53 codon 72 exon 4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population. Lung Cancer 62 (2008) 152-162
43. Jung H.Y., Whang Y.M., Sung J.S., Shin H.D., Park B.L., Kim J.S., et al. Association study of TP53 polymorphisms with lung cancer in a Korean population. J Hum Genet 53 (2008) 508-514
44. Zhang J.H., Li Y., Wang R., Wen D.G., Wu M.L., and He M. P53 gene polymorphism with susceptibility to esophageal cancer and lung cancer in Chinese population. Chin J Oncol 25 (2003) 365-367 [in Chinese]
45. Vousden K., and Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2 (2002) 594-604
46. Robles A.I., Linke S.P., and Harris C.C. The p53 network in lung carcinogenesis. Oncogene 21 (2002) 6898-6907
47. Dumont P., Leu J.I., Della Pietra III A.C., George D.L., and Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33 (2003) 357-365
48. Hirschhorn J.N., Lohmueller K., and Byrne E. A comprehensive review of genetic association studies. Genet Med 4 (2002) 45-61
49. Sjalander A., Birgander R., Kivela A., and Beckman G. p53 polymorphisms and haplotypes in different ethnic groups. Hum Hered 45 (1995) 144-149
50. Sato S., Nakamura Y., and Tsuchiya E. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 54 (1994) 5652-5655
51. Rodin S.N., and Rodin A.S. Human lung cancer and p53: the interplay between mutagenesis and selection. Proc Natl Acad Sci USA 97 (2000) 12244-12249
52. Rodriguez C., Calle E.E., Miracle-McMahill H.L., et al. Family history and risk of fatal prostate cancer. Epidemiology 8 (1997) 653-659